Diabetes Drug Breakthrough: Lixisenatide Slows Parkinson’s Progression, Researchers Reveal
London, England – A recent study suggests that a diabetes drug called lixisenatide may be able to slow down the progression of Parkinson’s disease symptoms. Parkinson’s is a neurodegenerative disorder affecting more than 10 million people worldwide, leading to movement, balance, and memory issues over time. While treatments can help manage symptoms, there is currently no cure available. In the realm of medical research, glucagon-like peptide 1 receptor agonists, specifically a diabetes medication known as …